Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Linking APP with Cell Cycle Reentry and Apoptosis—One Kinase Does the Trick
9 August 2003. Contentions that activation of the cell cycle and apoptosis at least partly underlie the neurodegeneration seen in Alzheimer's disease (AD) have slowly gained experimental support (see ARF related news story, ARF live discussion, and ARF recent live discussion). Now, a report in the July 30 Journal of Neuroscience suggests that not only are both activated by familial AD mutations, but that the two pathways are intimately linked through PAK3, a kinase that is activated by the Rho family member, p21.

Rachel Neve and colleagues at McLean Hospital, Belmont, Massachusetts, together with coworkers in the private sector and at Oregon Health and Science University, Portland, made the connection after they found that mutants of amyloidβ precursor protein (AβPP) known to cause familial AD also lead to apoptosis and DNA synthesis in primary neurons cultured from rats. To understand the molecular basis for these responses, first author Donna McPhie and colleagues used a radiolabeled C-terminal fragment of AβPP to screen rat cDNA libraries for potential binding partners. After several rounds of screening they isolated only one protein that bound tightly to the fragment, PAK3.

To determine if the binding of AβPP mutants with PAK3 is physiologically relevant, McPhie expressed both proteins in primary neurons and then looked for evidence of their interaction. When the authors incubated cell extracts with anti-AβPP antibodies both proteins were precipitated, suggesting that they interact in the cell. Furthermore, using immunohistochemical analysis, McPhie found the two proteins co-localized in neurons, primarily in endosomes.

But what of the role of PAK3? The authors found that in the presence of a dominant though inactive variant of the protein, AβPP mutants failed to induce apoptosis or DNA synthesis, indicating that PAK3 plays a vital role in these responses. However, this response also did not occur in these cells when the authors expressed a dominant active form of PAK3 alone, indicating that the interaction between the kinase and the mutant precursor protein is critical.

PAK family members are known to interact with the G protein family of cell signaling molecules, as is AβPP. To test if G proteins may also be involved in re-entry into the cell cycle or the apoptotic pathway, the authors expressed mutated AβPP in cultured neurons in the presence or absence of pertussis toxin, a well known poisoner of G protein signaling. They found that the toxin does indeed block the action of the AβPP mutants indicating that PAK3, G proteins, and AβPP are all inextricably linked in the neurodegeneration caused by the amyloid precursor.-Tom Fagan.

Reference:
McPhie DL, Coopersmith R, Hines-Peralta A, Chen Y, Ivins KJ, Manly SP, Kozlowski MR, Neve KA, Neve RL. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J. Neurosci. 2003 July 30;23:6914-6927. Abstract

 
Comments on News and Primary Papers
  Comment by:  Inez Vincent, ARF Advisor
Submitted 18 August 2003  |  Permalink Posted 18 August 2003

McPhie et al. have done a beautiful job unraveling the signaling pathway linking FAD mutants of APP and neuronal apoptosis. Their evidence that reentry into the cell cycle is an obligatory step in this APP-induced apoptotic cascade is compelling. I'm intrigued by some similarities between the APP-driven mechanism described by McPhie and colleagues and what is seen in Niemann-Pick Type C disease:

Mutations of both the APP gene and the NPC1 gene in humans lead to activation of similar cell cycle markers, cytoskeletal pathology with neurofibrillary tangle formation, and widespread neurodegeneration.

Both proteins localize to transport vesicles and Rab-specific endosomal compartments. (Accumulation of b-amyloid in late endosomes has been described in NPC1 cells and in older NPC patients).

Therefore, I wonder if there is a critical link between the function of the endosome or transport vesicles and cell cycle regulation in postmitotic neurons; in other words, if neurons exit the cell cycle to become highly specialized communicative cells, they...  Read more


  Comment by:  Mariano Alvira
Submitted 19 August 2003  |  Permalink Posted 20 August 2003
  I recommend the Primary Papers

We have made an antibody to an orphan GPCR that stains very strongly human neurons with NFT and human platelets. Anybody interested in collaborating? Mariano Alvira, MD marianoa@lsbio.com 206-374-1180

View all comments by Mariano Alvira
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad